Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

December 31, 1997

Conditions
Head and Neck Cancer
Interventions
DRUG

porfiromycin

RADIATION

radiation therapy

Trial Locations (4)

20422

Veterans Affairs Medical Center - Washington, DC, Washington D.C.

53226

Medical College of Wisconsin, Milwaukee

61655-1466

Health Advance Institute, Peoria

75235-9154

Simmons Cancer Center - Dallas, Dallas

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY